Cancer Genetics Inc. (CGIX) declined -6.9% or -0.02 to $0.27. It is close to 944762 shares traded, which is 28.58% compare to the average total volume 3.31 million. The market cap of CGIX is $11.09 million. The year to date change is 9.1%. The 52 week price range is from $0.2 to $2.2. Price of CGIX have changed 19.64% during last week. It have changed -25.64% over last month, -61.44% over last 3 months, -70.41% over last 6 months and -84.74% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CGIX is 0.29. It is 7.41% above current price. The 200-day Moving Averages for CGIX is 0.77. It is 185.19% above current price. The 52-week High is 2.2. It is 714.81% from the current price. The 52-week Low is 0.2. It is -25.93% from current price.
There are some statistics of CGIX. It is has market cap $11.09 million. The share outstanding is 41.06 million. The average volume is 3.31 million. The percent of top 15 Institution holding is 15.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CGIX is -122.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CGIX is -52.54%.